The association of α-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study

Laura J. Rasmussen-Torvik, Mary Cushman, Michael Y. Tsai, Yan Zhang, Susan R. Heckbert, Wayne D. Rosamond, Aaron R. Folsom

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


Introduction: The α-fibrinogen Thr312Ala variant has been shown to influence clot structure through increased factor XIII cross-linking and formation of thicker fibrin fibers. However, the effect of this common variant on risk of venous thromboembolism (VTE) is unclear. This paper reports the association between the Thr312Ala variant and VTE in the LITE study. Materials and methods: 506 cases and 1014 controls frequency matched on age, sex, race, and study were drawn from two prospective studies and included in the analysis. Logistic regression was used to examine the association between Thr312Ala and VTE. Results: In a logistic regression model minimally adjusted for the matching variables, the Thr312Ala TA and AA genotypes were associated with a significantly higher risk of VTE than the TT genotype (TA OR and 95% confidence interval 1.27 [1.01-1.60], AA OR 1.49 [1.00-2.22]). Associations were similar in analyses of PE and DVT considered separately and across racial and study subgroups. The association between α-fibrinogen Thr312Ala and VTE was modified by both BMI and the FXIII Val34Leu variant; the combination of elevated BMI or FXIII Val34Leu with α-fibrinogen Thr312Ala conveyed lower odds of VTE than would be expected by an additive or multiplicative model of individual risk factors. Conclusions: These results suggest that α-fibrinogen Thr312Ala is involved in the pathogenesis of VTE and that its action may be modified by other VTE risk factors.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalThrombosis Research
Issue number1
StatePublished - 2007

Bibliographical note

Funding Information:
The authors thank the staff and participants of the ARIC and CHS projects for long-term contributions. Ms. Rasmussen-Torvik is supported by NHLBI training grant T32 HL07972. The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022. The Cardiovascular Health Study was funded by contracts N01-HC-85079 to N01-HC-85086 and N01-HC-75150 and N01-HC-45133 from the National Heart, Lung, and Blood Institute. The LITE study was funded by R01 HL59367 from the National Heart, Lung, and Blood Institute.


  • Deep vein thrombosis
  • Fibrinogen
  • Polymorphism


Dive into the research topics of 'The association of α-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study'. Together they form a unique fingerprint.

Cite this